Monoclonal antibody treatment for COVID-19 could be a game changer
The Hindu
But the timing for administering the treatment is key, say doctors
Monoclonal antibody treatment is now seen as a relatively effective and safer alternative in treating COVID-19 patients, with doctors stating that, as with any other drug, timing is very important for the administration of the therapy that’s touted as a game changer. “If given within 72 hours of the appearance of symptoms, it is proven to show good results and could be the way forward in tackling the SARS-CoV-2 virus,” doctors note. Monoclonal antibodies have previously been used to treat infections such as Ebola and HIV. The therapy is now said to help avoid hospitalisation in high-risk groups, progression to severe disease, and to reduce the usage of steroids.More Related News

The Shivamogga district judiciary and administration jointly launched 1,234 legal literacy clubs across schools in one go in Shivamogga on January 22. The clubs, aimed at spreading awareness about rights, duties and laws among students, have been set up in select government, aided and private schools as well as pre-university colleges across the district.












